Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Indivior PLC, commonly known as Indivior, is a prominent pharmaceutical company headquartered in the US. Specialising in pharmaceutical preparation manufacturing, Indivior is dedicated to addressing serious mental health conditions and addiction globally.
Spun out from Reckitt Benckiser in December 2014, Indivior has since established itself as a leader in innovative treatments. Its core portfolio includes long-acting injectable therapies such as Sublocade® for opioid use disorder and Perseris® for schizophrenia, offering unique patient benefits by reducing daily medication burdens.
With a strong focus on pioneering solutions, Indivior maintains a significant market position in addiction treatment. The company operates across key regions including North America, Europe, and Asia Pacific, driving advancements in patient care.
+2 vs industry average
Indivior’s score of 44 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
Indivior, a US-headquartered pharmaceutical preparation manufacturer, reported total carbon emissions of approximately 141,510,000 kg CO2e in 2024. This includes 6,986,000 kg CO2e from Scope 1 emissions, 5,174,000 kg CO2e from market-based Scope 2 emissions, and 129,350,000 kg CO2e from Scope 3 emissions. In 2023, their total emissions were about 114,718,000 kg CO2e, comprising 4,573,000 kg CO2e (Scope 1), 2,366,000 kg CO2e (market-based Scope 2), and 107,779,000 kg CO2e (Scope 3).
Indivior aims for a 100% transition to hybrid vehicles by the end of 2026, impacting both Scope 1 and Scope 2 emissions. The company also outlines a long-term net-zero commitment by 2050, assuming a globally coordinated decarbonisation effort, which covers both Scope 1 and Scope 2 emissions. All emissions data and reduction targets are directly reported by Indivior PLC.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more